X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
index medicus (55) 55
female (45) 45
male (45) 45
middle aged (40) 40
aged (36) 36
abridged index medicus (35) 35
cardiovascular disease (33) 33
cardiac & cardiovascular systems (28) 28
risk factors (25) 25
statins (24) 24
cardiovascular (22) 22
simvastatin (22) 22
simvastatin - therapeutic use (21) 21
double-blind method (20) 20
cholesterol (19) 19
anticholesteremic agents - therapeutic use (18) 18
treatment outcome (18) 18
cardiology (17) 17
drug therapy (16) 16
cholesterol, ldl - blood (15) 15
heart attacks (15) 15
lipids (15) 15
medical and health sciences (15) 15
medicin och hälsovetenskap (15) 15
analysis (14) 14
clinical trials (14) 14
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (14) 14
prospective studies (14) 14
adult (12) 12
follow-up studies (12) 12
low density lipoproteins (12) 12
patients (12) 12
aged, 80 and over (11) 11
cardiovascular agents (11) 11
care and treatment (11) 11
internal medicine (11) 11
medical research (11) 11
risk (11) 11
studies (11) 11
cardiovascular diseases (10) 10
clinical medicine (10) 10
drug therapy, combination (10) 10
ezetimibe (10) 10
low density lipoprotein (10) 10
medicine, general & internal (10) 10
mortality (10) 10
myocardial infarction (10) 10
myocardial-infarction (10) 10
prevention (10) 10
stroke (10) 10
aortic valve stenosis (9) 9
cardiac patients (9) 9
coronary heart disease (9) 9
coronary-heart-disease (9) 9
disease progression (9) 9
heart attack (9) 9
medicine (9) 9
research (9) 9
aortic valve stenosis - drug therapy (8) 8
diabetes (8) 8
heart failure (8) 8
hypertension (8) 8
klinisk medicin (8) 8
randomized controlled trials as topic (8) 8
atherosclerosis (7) 7
atorvastatin calcium (7) 7
blood cholesterol (7) 7
blood pressure (7) 7
coronary disease - drug therapy (7) 7
disease (7) 7
health risk assessment (7) 7
hydroxymethylglutaryl-coa reductase inhibitors (7) 7
medicin (7) 7
myocardial infarction - prevention & control (7) 7
time factors (7) 7
azetidines - therapeutic use (6) 6
cardiac and cardiovascular systems (6) 6
cardiovascular diseases - prevention & control (6) 6
cholesterol, hdl - blood (6) 6
comparative analysis (6) 6
coronary artery disease (6) 6
coronary disease - mortality (6) 6
coronary disease - prevention & control (6) 6
dose-response relationship, drug (6) 6
events (6) 6
health aspects (6) 6
heart diseases (6) 6
heptanoic acids - therapeutic use (6) 6
hypercholesterolemia - drug therapy (6) 6
incidence (6) 6
kardiologi (6) 6
medical colleges (6) 6
outcomes (6) 6
physiological aspects (6) 6
pravastatin (6) 6
prognosis (6) 6
pyrroles - therapeutic use (6) 6
statin therapy (6) 6
anticholesteremic agents - adverse effects (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 2, pp. e16 - e16
Journal Article
by Swerdlow, Daniel I, Dr and Preiss, David, Dr and Kuchenbaecker, Karoline B, MSc and Holmes, Michael V, PhD and Engmann, Jorgen E L, MSc and Shah, Tina, PhD and Sofat, Reecha, MD and Stender, Stefan, MD and Johnson, Paul C D, PhD and Scott, Robert A, PhD and Leusink, Maarten, MSc and Verweij, Niek, MD and Sharp, Stephen J, MSc and Guo, Yiran, PhD and Giambartolomei, Claudia, MSc and Chung, Christina, MSc and Peasey, Anne, PhD and Amuzu, Antoinette, MSc and Li, KaWah, MSc and Palmen, Jutta, MSc and Howard, Philip, MSc and Cooper, Jackie A, MSc and Drenos, Fotios, PhD and Li, Yun R, BSc and Lowe, Gordon, Prof and Gallacher, John, PhD and Stewart, Marlene C W, PhD and Tzoulaki, Ioanna, PhD and Buxbaum, Sarah G, PhD and van der A, Daphne L, PhD and Forouhi, Nita G, MRCP and Onland-Moret, N Charlotte, PhD and van der Schouw, Yvonne T, Prof and Schnabel, Renate B, MD and Hubacek, Jaroslav A, PhD and Kubinova, Ruzena, MD and Baceviciene, Migle, MD and Tamosiunas, Abdonas, Prof and Pajak, Andrzej, Prof and Topor-Madry, Romanvan, MD and Stepaniak, Urszula, PhD and Malyutina, Sofia, Prof and Baldassarre, Damiano, PhD and Sennblad, Bengt, PhD and Tremoli, Elena, Prof and de Faire, Ulf, Prof and Veglia, Fabrizio, PhD and Ford, Ian, Prof and Jukema, J Wouter, Prof and Westendorp, Rudi G J, Prof and de Borst, Gert Jan, MD and de Jong, Pim A, MD and Algra, Ale, Prof and Spiering, Wilko, MD and der Zee, Anke H Maitland-van, PhD and Klungel, Olaf H, PharmD and de Boer, Anthonius, Prof and Doevendans, Pieter A, Prof and Eaton, Charles B, Prof and Robinson, Jennifer G, Prof and Duggan, David, PhD and Kjekshus, John, Prof and Downs, John R, MD and Gotto, Antonio M, MD and Keech, Anthony C, MD and Marchioli, Roberto, MD and Tognoni, Gianni, MD and Sever, Peter S, Prof and Poulter, Neil R, Prof and Waters, David D, MD and Pedersen, Terje R, MD and Amarenco, Pierre, MD and Nakamura, Haruo, MD and McMurray, John J V, Prof and Lewsey, James D, PhD and Chasman, Daniel I, PhD and Ridker, Paul M, MD and Maggioni, Aldo P, Prof and Tavazzi, Luigi, Prof and Ray, Kausik K, Prof and Seshasai, Sreenivasa Rao Kondapally, MD and Manson, JoAnn E, Prof and Price, Jackie F, MD and Whincup, Peter H, Prof and Morris, Richard W, Prof and Lawlor, Debbie A, Prof and Smith, George Davey, Prof and Ben-Shlomo, Yoav, Prof and Schreiner, Pamela J, Prof and Fornage, Myriam, Prof and Siscovick, David S, Prof and Cushman, Mary, MD and Kumari, Meena, PhD and Wareham, Nick J, Prof and Verschuren, W M Monique, PhD and Redline, Susan, Prof and Patel, Sanjay R, MD and Whittaker, John C, Prof and Hamsten, Anders, Prof and Delaney, Joseph A, PhD and ... and MAGIC Consortium and InterAct Consortium and DIAGRAM Consortium
The Lancet, ISSN 0140-6736, 01/2015, Volume 385, Issue 9965, pp. 351 - 361
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 18, pp. 1934 - 1934
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 173, pp. 94 - 101
Background Despite current therapies, patients with vascular disease remain at high risk for major adverse cardiovascular events. Low-density lipoprotein... 
Cardiovascular | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | EVOLOCUMAB AMG 145 | STATIN THERAPY | LDL-C | LOW-DENSITY-LIPOPROTEIN | PRIMARY-PREVENTION TRIAL | MONOCLONAL-ANTIBODY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Incidence | Dose-Response Relationship, Drug | Cholesterol, VLDL - drug effects | Injections, Subcutaneous | Lipoproteins, LDL - drug effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Female | Serine Endopeptidases | Drug Therapy, Combination | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Risk Factors | Treatment Outcome | Cholesterol, VLDL - blood | Australia - epidemiology | Antibodies, Monoclonal - administration & dosage | Norway - epidemiology | United Kingdom - epidemiology | Lipoproteins, LDL - blood | Proprotein Convertase 9 | Monoclonal antibodies | Blood circulation disorders | Low density lipoproteins | Risk factors | Vascular diseases | Clinical trials | Cardiovascular disease | Lipids | Cardiovascular diseases | Low density lipoprotein | Statins | Morbidity | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 8, pp. 911 - 921
Abstract Background Ezetimibe improves cardiovascular (CV) outcomes in patients stabilized after acute coronary syndrome (ACS) when added to statin therapy.... 
Cardiovascular | Internal Medicine | simvastatin | acute coronary syndrome | risk stratification | secondary prevention | ezetimibe | low-density lipoprotein cholesterol | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | EFFICACY | ACUTE CORONARY SYNDROMES | PREVIOUS MYOCARDIAL-INFARCTION | ATORVASTATIN | TRIAL | HEART-DISEASE | STATIN THERAPY | VORAPAXAR | Simvastatin - therapeutic use | Prospective Studies | Risk Assessment | Humans | Middle Aged | Male | Treatment Outcome | Secondary Prevention | Acute Coronary Syndrome - complications | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Acute Coronary Syndrome - therapy | Female | Aged | Ezetimibe - therapeutic use | Myocardial Infarction - prevention & control | Medical colleges | Continuing medical education | Cardiology | Coronary heart disease | Medicine, Preventive | Statins | Cardiovascular agents | Preventive health services | Prevention | Medical research | Low density lipoproteins | Medicine, Experimental | Hypertension | Heart failure | Stroke | Heart attacks | Cardiovascular disease | Lipids | Angina pectoris | Low density lipoprotein | Patients | Cholesterol | Disease prevention | Coronary vessels | Electrocardiography | Population | Diabetes | Kidney diseases | Health risk assessment | Acute coronary syndromes | Age | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 7, pp. 970 - 973
Aortic valve stenosis and atherosclerotic disease have several risk factors in common, in particular, hypercholesterolemia. Histologically, the diseased valves... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | DISEASE | AGE | Aortic Valve Stenosis - drug therapy | Simvastatin - therapeutic use | Follow-Up Studies | Ventricular Function, Left | Humans | Middle Aged | Ezetimibe | Aortic Valve Stenosis - blood | Male | Aortic Valve Stenosis - diagnostic imaging | Aged, 80 and over | Cholesterol, LDL - blood | Female | Drug Therapy, Combination | Echocardiography | Double-Blind Method | Cholesterol, HDL - drug effects | Europe | Aortic Valve Stenosis - physiopathology | Cholesterol, LDL - drug effects | Treatment Outcome | Disease Progression | Stroke Volume | Anticholesteremic Agents - therapeutic use | Azetidines - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Blood Flow Velocity - drug effects | Simvastatin | Aortic valve stenosis | Cholesterol | Antilipemic agents | Coronary vessels | Mortality | Clinical trials | Cardiovascular disease | Lipids | Drug therapy | Cardiology | Patients | Statins | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Flow Velocity/drug effects | Aortic Valve Stenosis/blood/drug therapy/physiopathology/ultrasonography | Simvastatin/therapeutic use | Ventricular Function; Left | Cholesterol; LDL/blood/drug effects | Anticholesteremic Agents/therapeutic use | Cholesterol; HDL/blood/drug effects | Triglycerides/blood | Aged; 80 and over | Drug Therapy; Combination | Azetidines/therapeutic use
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2009, Volume 104, Issue 4, pp. 459 - 463
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2010, Volume 105, Issue 12, pp. 1802 - 1808
In the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial, combined ezetimibe (10 mg) and simvastatin (40 mg) decreased low-density lipoprotein... 
Cardiovascular | RATIOS | SEAS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CHOLESTEROL | DISEASE | RISK | Aortic Valve Stenosis - drug therapy | Simvastatin - therapeutic use | Prognosis | Follow-Up Studies | Humans | Middle Aged | Ezetimibe | Male | Apolipoproteins B - blood | Apolipoproteins B - drug effects | Atherosclerosis - epidemiology | Aortic Valve Stenosis - diagnostic imaging | Incidence | Dose-Response Relationship, Drug | Time Factors | Echocardiography, Doppler | Aged, 80 and over | Cholesterol, LDL - blood | Female | Drug Therapy, Combination | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Disease Progression | Atherosclerosis - blood | Aortic Valve Stenosis - complications | Anticholesteremic Agents - therapeutic use | Azetidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Cholesterol, HDL - blood | Aged | Atherosclerosis - prevention & control | Medical research | Cardiovascular disease | Cardiology | Low density lipoprotein | Coronary vessels | Statins | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Internal medicine | Medicin och hälsovetenskap | Klinisk medicin | MEDICINE | Dermatology and venerology,clinical genetics, internal medicine | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | MEDICIN | Invärtesmedicin | Dermatologi och venerologi, klinisk genetik, invärtesmedicin
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 10, pp. 1518 - 1522
Journal Article
16.